Publication Procedure. At the end of the research, the publishable part of the Results will be described in the final report as defined under section 4.4.3. Review of publications Any publication or communication, whether written or oral, in connection with Result is required to be submitted to the Collaborative Board. To this end, the full text of the proposed publication or communication shall be submitted to the Collaborative Board. If the Collaborative Research Project has established a secure web site, then the full text can be submitted through it. Each member of the Collaborative Board will have the possibility to appoint one or several internal expert(s) to assess the content of the publication. Each member of the Collaborative Board will have one (1) calendar month from the date of submission of the publication to object to it in writing to the Chair. Beyond this period, if no objection has been received consent shall be deemed to have been given. This obligation, nonetheless, should not prevent the application of a Patent in accordance with the provisions of this Consortium Agreement, nor should it unnecessarily prevent a possible commercial use.
Appears in 1 contract
Sources: Consortium Agreement
Publication Procedure. At the end of the research, the publishable part of the Results will be described in the final report as defined under section 4.4.3. Review of publications Any publication or communication, whether written or oral, in connection with Result is required to be submitted to the Collaborative Board. To this end, the full text of the proposed publication or communication shall be submitted to the Collaborative Board. If the Collaborative Research Project has established a secure web site, then the full text can be submitted through it. Each member of the Collaborative Board will have the possibility to appoint one or several internal expert(s) to assess the content of the publication. Each member of the Collaborative Board will have one (1) calendar month from the date of submission of the publication to object to it it in writing to the ChairChairman. Beyond this period, if no objection has been received consent shall be deemed to have been given. This obligation, nonetheless, should not prevent the application of a Patent in accordance with the provisions of this Consortium Agreement, nor should it unnecessarily prevent a possible commercial use.
Appears in 1 contract
Sources: Consortium Agreement